This is in reply to the Letter by Kahathuduwa et al. titled 'Unaccounted for regression to the mean renders conclusion of article titled ‘Uric acid lowering in relation to HbA1c reductions with the SGLT2 inhibitor Tofogliflozin’ unsubstantiated'

Authors :: Akihiro Yoshida
Hideki Suganami
Tomoe Fujita
Masahiro Yasutake
Kenzo Oba
Motoshi Ouchi
Kohei Kaku
Tatsuya Suzuki
Source :: Diabetes, Obesity and Metabolism. 20:2041-2042
Publication Year :: 2018
Publisher :: Wiley, 2018.

Full Text Access

Tools